Immune to Cancer: The CRI Blog
-
Patient Immunotherapy Summit: Breast Cancer Brief
While one in eight women in the U.S. will develop breast cancer in their lifetime, the good… -
Patient Immunotherapy Summit: I’m the Answer to Cancer™ Jeff’s Patient Story
Since immunotherapy has become a more mainstream form of cancer treatment, more people are choosing to use… -
Patient Immunotherapy Summit: Ovarian Cancer Brief
It is important for the public to be aware of the scope of ovarian cancer, as over… -
Patient Immunotherapy Summit: Pancreatic Cancer Brief
Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading… -
Immunotherapy 101: What is Immunotherapy and How Does it Work?
Jedd Wolchok, MD, PhD, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill… -
CRI’s 7th Annual Patient Immunotherapy Summit – December 2023 Full Cut
The Cancer Research Institute’s 7th Annual Patient Immunotherapy Summit hosts a plethora of impactful information that cancer… -
Exploring the Different Types of Cancer and Treatment Options
Cancer is a formidable adversary, but our understanding of this disease has come a long way. Cancer… -
Unraveling the Pro-Tumorigenic Myelopoiesis Driven by an IL-4 Signaling Axis in Bone Marrow
CRI is delighted to share the latest milestone achievement from CRI-supported investigators at Icahn School of Medicine… -
CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide
A Large Cancer Presence on a Global Scale The Cancer Research Institute (CRI) has a singular focus:…